Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Fox E, Edwards K, Burch G, Wynn DR, Laganke C, Crayton H, Hunter SF, Huffman C, Kim E, Pestreich L, et al.